← Leaderboards
Anthony P. Sinai
University Of Kentucky
$5,802,259
Attributed
$6,363,470
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $800.3K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,363,470 · 9
By mechanism
R01$3,761,121 · 2
R21$2,453,849 · 6
R03$148,500 · 1
Top collaborators
- Abhijit R. Patwardhan3 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Abhijit R. Patwardhan$883,268
Others in their field
Top investigators on “Toxoplasma Gondii”
- L David Sibley · Washington University$42,221,391
- John C Boothroyd · Stanford University$21,342,994
- Christopher A Hunter · University Of Pennsylvania$20,595,527
- Michael W White · University Of California Riverside$17,265,886
- Vernon Bruce Carruthers · Johns Hopkins University$15,672,870
- Gary E Ward · University Of Vermont & St Agric College$14,197,597
Research focus
Toxoplasma GondiiInfectionParasitesToxoplasmaBaseToxoplasmosisInsightCystAcquired Immunodeficiency SyndromePathogenMediatingBiologyAcutePathogenesisGenesSignal TransductionTechnologyLinkExhibitsGrowthMitochondriaLifeEventMetabolism
Grant awards (26)
Quantitative Approaches for Drug Testing in Chronic Toxoplasmosis: Leveraging New Insights Into Bradyzoite Biology Within Tissue Cysts In Vivo$379,562
R01 · FY2021 · AI · contact PI
Role of amylopectin granules in chronic toxoplasmosis, an HIV-AIDS defining infection$229,500
R21 · FY2021 · AI · contact PI
Extragenic adaptation to the loss of a deubiquitinase affecting the T. gondii cell cycle and development$191,250
R21 · FY2021 · AI · contact PI
Quantitative Approaches for Drug Testing in Chronic Toxoplasmosis: Leveraging New Insights Into Bradyzoite Biology Within Tissue Cysts In Vivo$374,141
R01 · FY2020 · AI · contact PI
Extragenic adaptation to the loss of a deubiquitinase affecting the T. gondii cell cycle and development$229,500
R21 · FY2020 · AI · contact PI
Role of amylopectin granules in chronic toxoplasmosis, an HIV-AIDS defining infection$191,250
R21 · FY2020 · AI · contact PI
Quantitative Approaches for Drug Testing in Chronic Toxoplasmosis: Leveraging New Insights Into Bradyzoite Biology Within Tissue Cysts In Vivo$368,720
R01 · FY2019 · AI · contact PI
The cell cycle of T. gondii bradyzoites within tissue cysts:in vivo development of an HIV-AIDS opportunistic parasite$188,125
R21 · FY2017 · AI · contact PI
The cell cycle of T. gondii bradyzoites within tissue cysts:in vivo development of an HIV-AIDS opportunistic parasite$225,750
R21 · FY2016 · AI · contact PI
Host glycosyltransferases in the glycosylation of Toxoplasma proteins$222,750
R21 · FY2014 · AI · contact PI
Host glycosyltransferases in the glycosylation of Toxoplasma proteins$185,625
R21 · FY2013 · AI · contact PI
Contribution of N-glycosylation to the Toxoplasma glycoproteome$180,193
R21 · FY2013 · AI · contact PI
Contribution of N-glycosylation to the Toxoplasma glycoproteome$217,318
R21 · FY2012 · AI · contact PI
Novel activities and the T. gondii vacuolar membrane$74,250
R03 · FY2012 · AI · contact PI
Novel activities and the T. gondii vacuolar membrane$74,250
R03 · FY2011 · AI · contact PI
Blockade of host apoptosis by Toxoplasma gondii$310,845
R01 · FY2010 · AI · contact PI
Blockade of host apoptosis by Toxoplasma gondii$313,985
R01 · FY2009 · AI · contact PI
Blockade of host apoptosis by Toxoplasma gondii$350,610
R01 · FY2008 · AI · contact PI
Blockade of host apoptosis by Toxoplasma gondii$320,066
R01 · FY2007 · AI · contact PI
Blockade of host apoptosis by Toxoplasma gondii$329,475
R01 · FY2006 · AI · contact PI
Proteomic analysis of the T. gondii vacuolar membrane$175,870
R21 · FY2006 · AI · contact PI
Proteomic analysis of the T. gondii vacuolar membrane$216,718
R21 · FY2005 · AI
Blockade of host apoptosis by Toxoplasma gondii$253,400
R01 · FY2004 · AI
Blockade of host apoptosis by Toxoplasma gondii$253,400
R01 · FY2003 · AI
Blockade of host apoptosis by Toxoplasma gondii$253,400
R01 · FY2002 · AI
Blockade of host apoptosis by Toxoplasma gondii$253,517
R01 · FY2001 · AI